Why is Apollo Hospitals falling/rising?

As of 21-Aug, Apollo Hospitals Enterprise Ltd. is experiencing a price increase, currently at ₹7,916.30, reflecting a rise of ₹43.3 or 0.55%. The stock has recently hit a new 52-week and all-time high of ₹7,946.85 and has outperformed its sector by 0.87%. Over the past week, the stock has gained 1.19%, and in the last month, it has risen by 8.91%. Despite a slight decline in delivery volume, which fell by 27.85% against the 5-day average, the stock remains liquid enough for trading. The company has demonstrated strong performance with a high return on capital employed (ROCE) of 15.08%, consistent positive results over the last seven quarters, and significant growth in net sales and operating profit, contributing to its favorable valuation compared to peers.
In the broader market context, while the Sensex has increased by 1.74% over the past week, Apollo Hospitals has slightly underperformed in this timeframe. However, the stock has shown remarkable long-term performance, with a 91.36% increase over the past three years, significantly outpacing the benchmark's 37.48% rise. The company’s high institutional holdings at 65.05% suggest strong confidence from knowledgeable investors, further supporting its upward trajectory. Overall, Apollo Hospitals' robust financial metrics and consistent growth have contributed to its rising stock price, despite some short-term fluctuations in trading volume.